IRIS
GRAVINA, GIOVANNI LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.291
EU - Europa 7.589
AS - Asia 6.884
SA - Sud America 891
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 92
OC - Oceania 15
Totale 28.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.081
SG - Singapore 2.847
CN - Cina 1.567
IE - Irlanda 1.510
RU - Federazione Russa 1.396
IT - Italia 1.127
TR - Turchia 848
DE - Germania 814
SE - Svezia 783
BR - Brasile 766
HK - Hong Kong 683
GB - Regno Unito 528
VN - Vietnam 502
UA - Ucraina 446
FR - Francia 372
FI - Finlandia 292
CA - Canada 128
IN - India 97
BE - Belgio 77
BD - Bangladesh 72
NL - Olanda 70
JP - Giappone 68
AR - Argentina 43
ES - Italia 42
MX - Messico 40
ZA - Sudafrica 37
IQ - Iraq 32
CZ - Repubblica Ceca 29
PL - Polonia 25
ID - Indonesia 23
MA - Marocco 19
PK - Pakistan 19
EU - Europa 18
VE - Venezuela 17
CO - Colombia 14
MY - Malesia 14
EC - Ecuador 13
LT - Lituania 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
CL - Cile 11
AT - Austria 10
IL - Israele 10
KR - Corea 10
UZ - Uzbekistan 10
PH - Filippine 9
PE - Perù 8
AL - Albania 7
JM - Giamaica 7
JO - Giordania 7
RO - Romania 7
PT - Portogallo 6
PY - Paraguay 6
UY - Uruguay 6
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
DZ - Algeria 5
EG - Egitto 5
KE - Kenya 5
NI - Nicaragua 5
NP - Nepal 5
BG - Bulgaria 4
GE - Georgia 4
GT - Guatemala 4
KZ - Kazakistan 4
MD - Moldavia 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GY - Guiana 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
LY - Libia 2
MK - Macedonia 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TL - Timor Orientale 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
Totale 28.758
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.736
Singapore 1.665
Chandler 1.654
Dublin 1.504
San Jose 1.247
Dallas 1.080
Ashburn 751
Hong Kong 669
Santa Clara 572
Boardman 563
Izmir 448
Council Bluffs 356
Nanjing 337
Ann Arbor 327
New York 315
The Dalles 312
San Mateo 304
Wilmington 298
Moscow 252
L’Aquila 240
Princeton 232
Lawrence 231
Beijing 190
Ho Chi Minh City 165
Lauterbourg 164
Milan 157
Los Angeles 147
Munich 130
Nanchang 120
Bremen 111
Hanoi 110
L'aquila 106
Woodbridge 101
Seattle 100
Shenyang 78
São Paulo 78
Brussels 76
Verona 70
Hefei 63
Tokyo 63
Hebei 62
Helsinki 60
Mountain View 58
Kunming 57
Rome 55
Des Moines 54
Tianjin 54
Orem 52
Montreal 45
Jiaxing 44
Amsterdam 41
Changsha 40
Columbus 40
Falls Church 40
Norwalk 37
Chicago 35
Toronto 35
Frankfurt am Main 33
Belo Horizonte 31
Grafing 31
Jinan 30
Philadelphia 30
Shanghai 29
Chennai 28
Brooklyn 27
Dearborn 27
Dong Ket 26
Houston 26
Johannesburg 26
Phoenix 26
San Francisco 25
Turku 25
Boston 24
London 24
Guangzhou 23
Brno 22
Haiphong 21
Manchester 21
Ningbo 21
Da Nang 20
Stockholm 20
Zhengzhou 20
Denver 19
Rio de Janeiro 19
Warsaw 19
Atlanta 18
Auburn Hills 18
Falkenstein 18
Ankara 17
Buffalo 17
Lanzhou 17
Poplar 17
Hangzhou 16
Lappeenranta 16
Mexico City 16
Taizhou 16
Mumbai 15
Pune 15
Baghdad 14
Changchun 14
Totale 18.868
Salva come PNG Salva come JPEG
Nome #
TAMSULOSINA E TADALAFIL IN PAZIENTI CON IPERTROFIA PROSTATICA BENIGNA E DISFUNZIONE ERETTILE: NOSTRA ESPERIENZA CON LA TERAPIA COMBINATA A LUNGO TERMINE 315
320-row coronary computed tomography angiography (CCTA) with automatic exposure control (AEC): effect of 100 kV versus 120 kV on image quality and dose exposure 274
640-Slice CT Measurement of Superior Orbital Fissure as Gateway for Light into the Brain: Statistical Evaluation of Area and Distance 260
429) Human Endothelial Cells from H(2)O (2) Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation. 214
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells 203
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 202
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 196
From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis 188
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 181
Cross-cultural and socio-demographic correlates of homophobic attitude among university students in three European countries 181
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 178
Is Testosterone a Food for the Brain? 177
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 175
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 169
Bladder outlet obstruction index and maximal flow rate during urodynamic study as powerful predictors for the detection of urodynamic obstruction in women 167
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis 165
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 164
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 162
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 162
Epidemiology of delayed ejaculation 160
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 160
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 159
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 159
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 159
Vitamin D protects human endothelial cells from H₂O₂ oxidant injury through the Mek/Erk-Sirt1 axis activation 156
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 155
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 154
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 153
Role of SIRT1 in the adaptive response of mouse ovaries to radiotherapy (X ray radiations). 152
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 151
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 151
Topical application of platelet supernatant gel in the management of radiotherapy-induced mucositis: a case report 151
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 151
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 150
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. 149
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 149
Crocetin Mitigates Irradiation Injury in an In Vitro Model of the Pubertal Testis: Focus on Biological Effects and Molecular Mechanisms 149
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines 148
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 147
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 145
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 144
Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity 143
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 143
Carotid artery plaque characterization with a wide-detector computed tomography using a dedicated post-processing 3D analysis: comparison with histology 142
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 142
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 142
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population. 142
Alexithymia and vaginismus: a preliminary correlation perspective. 141
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 141
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 140
Challenges to treat hypogonadism in prostate cancer patients: Implications for endocrinologists, urologists and radiotherapists 140
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 139
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 138
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 137
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 137
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 137
Voluntary interruption of pregnancy worsens the Female sexual well-being 136
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 136
Trifluoroibuprofen inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in Vivo Tumor Growth in Aggressive Prostate Cancer Models. 135
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis 135
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 135
CT-guided cryoablation for management of bone metastases: a single center experience and review of the literature 135
Combination treatment with solifenacin and tamsulosin in men with overactive bladder (OAB) and bladder outlet obstruction (BOO) 134
Optimizing Nozzle Travel Time in Proton Therapy 133
Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment 133
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 133
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 132
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 132
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 132
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 131
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 131
Anthracycline‑based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5‑fluorouracil and radiation therapy in surgically resected axillary node‑positive breast cancer 131
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 131
Image quality and radiation dose of single heartbeat 640-slice coronary CT angiography: a comparison between patients with chronic Atrial Fibrillation and subjects in normal sinus rhythm by propensity analysis 130
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 130
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 130
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. 130
Assessment of dose exposure and image quality in coronary angiography performed by 640-slice CT: a comparison between adaptive iterative and filtered back-projection algorithm by propensity analysis 129
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 129
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 128
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 127
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models 127
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 127
The sexual attraction toward disabilities: a preliminary internet-based study. 126
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 126
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 126
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 126
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 125
Urodynamic Obstruction in Women With Stress Urinary Incontinence-Do Nonintubated Uroflowmetry and Symptoms Aid Diagnosis? 125
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 125
Urodynamic characterization of a female population with clinical SUI and concomitant symptoms suggestive of bladder outlet obstruction 124
L'aumento di neurotrofine è associato alla progressione del tumore della prostata in un modello animale murino 124
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 124
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa) 123
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 123
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 123
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals 123
Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: A single institutional experience 123
Editorial: Antitarget Therapies: New Frontiers in the Treatment of Cancer 122
Spread-Out Bragg Peak in Treatment Planning System by Mixed Integer Linear Programming: a Proof of Concept 121
Totale 14.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.472 0 129 331 103 66 66 29 86 98 59 101 404
2022/20234.693 316 268 67 557 484 525 6 286 1.957 40 95 92
2023/20241.258 386 73 49 153 72 302 28 48 5 25 30 87
2024/20254.604 117 89 359 230 581 388 667 397 964 203 351 258
2025/20269.189 380 817 758 1.164 830 719 1.578 321 807 1.027 586 202
2026/2027593 292 301 0 0 0 0 0 0 0 0 0 0
Totale 28.975